Chapter

Lipid-Lowering Clinical Trials and Medications

Joseph G. Murphy, R. Scott Wright and Thomas G. Allison

in Mayo Clinic Cardiology

Fourth edition

Published on behalf of © Mayo Foundation for Medical Education and Research

Published in print November 2012 | ISBN: 9780199915712
Published online May 2013 | e-ISBN: 9780199322824 | DOI: http://dx.doi.org/10.1093/med/9780199915712.003.1143

Series: Mayo Clinic Scientific Press

Lipid-Lowering Clinical Trials and Medications

Show Summary Details

Preview

This chapter reviews trials that studied the effect of diet and various lipid-lowering medications on reducing the risk of cardiovascular disease. Trials studying the effect of diet on cardiovascular risk were the Lyon Diet Heart Study, the DART trial, the Moradabad Heart Study, and the Step Two Plus Study. Trials studying the effect of statins, nicotinic acid, fibric acid derivatives, bile acid-binding sequestrants, ezetimibe, and other antiatherogenic agents are also reviewed.

Chapter.  11658 words.  Illustrated.

Subjects: Cardiovascular Medicine

Full text: subscription required

How to subscribe Recommend to my Librarian

Buy this work at Oxford University Press »

Users without a subscription are not able to see the full content. Please, subscribe or login to access all content.